.Merck beats revenues expectations, increases purchases outlook on solid demand for top drugs like Keytruda CNBCMerck & Co. (MRK United States) Defeats Revenue Estimates as Keytruda Purchases Growth BloombergMerck Supply: Pharma Giant Posts Sturdy Outcomes, Yet Overview Drops Short Client's Business DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck trumps profit as well as sales assumptions in the middle of Keytruda strength, yet provides combined full-year overview MarketWatch.